Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study, Neuropsychiatric Disease and Treatment (2011) Lisdexamfetamine dimesylate (Vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder, Pharmacy & Therapeutics (2010) Medication adherence and compliance: Recipe for improving patient outcomes, Pharmacy (2022) Label for Adderall, Teva Pharmaceuticals USA (2017) Label for Vyvanse, Shire U.S
Many patients report that maintaining stable, moderate meal sizes throughout the weekrather than restricting food at injection timeimproves tolerability and supports steady weight loss
10.1111/j.1365-2036.2011.04724.x 78 VogtN
Hims: The company's high-profile Super Bowl LIX ad in February 2025 promoting compounded GLP-1s prompted letters from U.S
Mills and Certified Weight Management provider Laura Beth Jones, CRNP, our weight loss program focuses on you
